TNFSF10 and colorectal carcinoma: To further evaluate whether CDK9 inhibition is sufficient to re-sensitize colon cancer cells to TRAIL-induced cell death, three TRAIL-resistant CRC cell lines were preincubated with Dinaciclib prior to TRAIL treatment.